Ying Shang

24PUBLICATIONS

53CO-AUTHORS

Metabolic medicineMedical biochemistry - lipidsNutritional epidemiologyMedical infection agents (incl. prions)Disease surveillance

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Jul 14, 2026

Comorbid type 2 diabetes and cardiovascular disease drive higher healthcare costs in MASLD/MASH: a retrospective Swedish cohort study.

|Mar 30, 2026

Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes.

Yuping Chen, Bingtian Dong, Xinrui Jin

|Dec 08, 2025

Editorial: MetALD and Risk of Gastrointestinal Cancer-What Can We Learn From Japan?

Hannes Hagström, Ying Shang

|Nov 20, 2025

Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case-control study in Sweden.

Joost Boeckmans, Linnea Widman, Rickard Strandberg

|Jun 20, 2025

Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.

Jimmy Che-To Lai, Boyu Yang, Hye Won Lee

|Oct 02, 2024

Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 Patients.

Max S Schechter, Linnea Widman, Axel Wester

Pageof 4

Frequent Collaborators

19 joint publications

Hannes Hagström

Axel Wester

Weili Xu

Linnea Widman

Elisabetta Bugianesi

Jérôme Boursier

Terry Cheuk-Fung Yip

Salvatore Petta

Seung Up Kim

Manuel Romero-Gomez

Frequent Collaborators

19 joint publications

Hannes Hagström

7 joint publications

Axel Wester

3 joint publications

Weili Xu

3 joint publications

Linnea Widman